Kusiak J W, Pitha J
Biochem Pharmacol. 1982 Jun 1;31(11):2071-6. doi: 10.1016/0006-2952(82)90423-3.
THe interaction of macromolecular alprenolol derivatives with beta-adrenoreceptors of rat heart, lung, and erythrocytes and frog erythrocytes has been studied. Macromolecular derivatives were prepared by covalently coupling alprenolol to dextrans containing a homologous series of spacer arms of various lengths. The affinity of these macromolecules for frog erythrocyte membranes increased with increasing length of spacer arm. In contrast, the affinity of these macromolecules for all mammalian membrane preparations was weak and insensitive to the length of the spacer arm. The inhibition of [3H]dihydroalprenolol binding to rat heart, lung, and erythrocyte membrane preparations by these macromolecular derivatives was more than 1000-fold less potent than inhibition by alprenolol. The results suggest different structural characteristics between mammalian and amphibian beta-adrenoreceptors; however, apparently only small differences between mammalian receptors could be distinguished with these probes.
已经研究了大分子阿普洛尔衍生物与大鼠心脏、肺和红细胞以及青蛙红细胞的β-肾上腺素受体的相互作用。通过将阿普洛尔与含有一系列不同长度间隔臂的葡聚糖共价偶联来制备大分子衍生物。这些大分子对青蛙红细胞膜的亲和力随着间隔臂长度的增加而增加。相反,这些大分子对所有哺乳动物膜制剂的亲和力较弱,且对间隔臂的长度不敏感。这些大分子衍生物对[3H]二氢阿普洛尔与大鼠心脏、肺和红细胞膜制剂结合的抑制作用比阿普洛尔的抑制作用弱1000倍以上。结果表明哺乳动物和两栖动物的β-肾上腺素受体之间存在不同的结构特征;然而,显然用这些探针只能区分哺乳动物受体之间的微小差异。